Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease.

BACKGROUND & AIMS The mechanisms of tissue destruction during progression of celiac disease are poorly defined. It is not clear how tissue stress and adaptive immunity contribute to the activation of intraepithelial cytotoxic T cells and the development of villous atrophy. We analyzed epithelial cells and intraepithelial cytotoxic T cells in family members of patients with celiac disease, who were without any signs of adaptive antigluten immunity, and in potential celiac disease patients, who have antibodies against tissue transglutaminase 2 in the absence of villous atrophy. METHODS We collected blood and intestinal biopsy specimens from 268 patients at tertiary medical centers in the United States and Italy from 2004 to 2012. All subjects had normal small intestinal histology. Study groups included healthy individuals with no family history of celiac disease or antibodies against tissue transglutaminase 2 (controls), healthy family members of patients with celiac disease, and potential celiac disease patients. Intraepithelial cytotoxic T cells were isolated and levels of inhibitory and activating natural killer (NK) cells were measured by flow cytometry. Levels of heat shock protein (HSP) and interleukin 15 were measured by immunohistochemistry, and ultrastructural alterations in intestinal epithelial cells (IECs) were assessed by electron microscopy. RESULTS IECs from subjects with a family history of celiac disease, but not from subjects who already had immunity to gluten, expressed higher levels of HS27, HSP70, and interleukin-15 than controls; their IECs also had ultrastructural alterations. Intraepithelial cytotoxic T cells from relatives of patients with celiac disease expressed higher levels of activating NK receptors than cells from controls, although at lower levels than patients with active celiac disease, and without loss of inhibitory receptors for NK cells. Intraepithelial cytotoxic T cells from potential celiac disease patients failed to up-regulate activating NK receptors. CONCLUSIONS A significant subset of healthy family members of patients with celiac disease with normal intestinal architecture had epithelial alterations, detectable by immunohistochemistry and electron microscopy. The adaptive immune response to gluten appears to act in synergy with epithelial stress to allow intraepithelial cytotoxic T cells to kill epithelial cells and induce villous atrophy in patients with active celiac disease.

[1]  M. Mearin,et al.  Local communication among mucosal immune cells in patients with celiac disease. , 2015, Gastroenterology.

[2]  L. Greco,et al.  Intestinal titres of anti‐tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten‐free diet duration in coeliac disease , 2014, Clinical and experimental immunology.

[3]  K. Kaukinen,et al.  Impaired epithelial integrity in the duodenal mucosa in early stages of celiac disease. , 2014, Translational research : the journal of laboratory and clinical medicine.

[4]  B. Jabri,et al.  IL‐15: a central regulator of celiac disease immunopathology , 2014, Immunological reviews.

[5]  L. Greco,et al.  Potential Celiac Children: 9-Year Follow-Up on a Gluten-Containing Diet , 2014, The American Journal of Gastroenterology.

[6]  H. Kiyono,et al.  Interleukin 15 and CD4⁺ T cells cooperate to promote small intestinal enteropathy in response to dietary antigen. , 2014, Gastroenterology.

[7]  C. Gianfrani,et al.  Immunoregulatory Pathways Are Active in the Small Intestinal Mucosa of Patients with Potential Celiac Disease , 2013, The American Journal of Gastroenterology.

[8]  T. Waldmann,et al.  Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα , 2013, Proceedings of the National Academy of Sciences.

[9]  L. Sollid,et al.  Triggers and drivers of autoimmunity: lessons from coeliac disease , 2013, Nature Reviews Immunology.

[10]  L. Sollid,et al.  The intestinal B-cell response in celiac disease , 2012, Front. Immun..

[11]  F. Koning Celiac disease: quantity matters , 2012, Seminars in Immunopathology.

[12]  B. Jabri,et al.  Intraepithelial lymphocytes in celiac disease immunopathology , 2012, Seminars in Immunopathology.

[13]  M. Mäki Coeliac disease: Lack of consensus regarding definitions of coeliac disease , 2012, Nature Reviews Gastroenterology &Hepatology.

[14]  D. Sanders,et al.  The Oslo definitions for coeliac disease and related terms , 2012, Gut.

[15]  L. Sollid,et al.  Abundance and unique repertoire of plasma cells secreting IgA autoantibodies to transglutaminase 2 in the intestinal lesion of celiac disease , 2012, Nature Medicine.

[16]  K. Giersiepen,et al.  European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease , 2012, Journal of pediatric gastroenterology and nutrition.

[17]  Y. Sanz,et al.  Unraveling the Ties between Celiac Disease and Intestinal Microbiota , 2011, International reviews of immunology.

[18]  C. Wijmenga,et al.  Shared genetics in coeliac disease and other immune‐mediated diseases , 2011, Journal of internal medicine.

[19]  R. Troncone,et al.  Coeliac disease and gluten sensitivity , 2011, Journal of internal medicine.

[20]  L. Greco,et al.  Natural history of potential celiac disease in children. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  L. Sollid,et al.  Integration of genetic and immunological insights into a model of celiac disease pathogenesis. , 2011, Annual review of immunology.

[22]  T. Waldmann,et al.  Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens , 2011, Nature.

[23]  A. Marchiando,et al.  Epithelial barriers in homeostasis and disease. , 2010, Annual review of pathology.

[24]  L. Sollid,et al.  Tissue-mediated control of immunopathology in coeliac disease , 2009, Nature Reviews Immunology.

[25]  Jerrold R. Turner,et al.  Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.

[26]  J. McCluskey,et al.  Resistance to Celiac Disease in Humanized HLA-DR3-DQ2-Transgenic Mice Expressing Specific Anti-Gliadin CD4+ T Cells1 , 2009, The Journal of Immunology.

[27]  M. Tretiakova,et al.  Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15 , 2009, The Journal of experimental medicine.

[28]  K. Kaukinen,et al.  Gluten-dependent Small Bowel Mucosal Transglutaminase 2–specific IgA Deposits in Overt and Mild Enteropathy Coeliac Disease , 2008, Journal of pediatric gastroenterology and nutrition.

[29]  S. Anant,et al.  Translational Inhibition of Colonic Epithelial Heat Shock Proteins by IFN-γ and TNF-α in Intestinal Inflammation , 2007 .

[30]  K. Kaukinen,et al.  Latent coeliac disease or coeliac disease beyond villous atrophy? , 2007, Gut.

[31]  M. Rewers,et al.  Rotavirus Infection Frequency and Risk of Celiac Disease Autoimmunity in Early Childhood: A Longitudinal Study , 2006, The American Journal of Gastroenterology.

[32]  L. Sollid,et al.  Mechanisms of Disease: immunopathogenesis of celiac disease , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[33]  T. Waldmann The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design , 2006, Nature Reviews Immunology.

[34]  K. Kaukinen,et al.  Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease , 2006, Alimentary pharmacology & therapeutics.

[35]  E. Kistner,et al.  Reprogramming of CTLs into natural killer–like cells in celiac disease , 2006, The Journal of experimental medicine.

[36]  L. Greco,et al.  Clinical, HLA, and Small Bowel Immunohistochemical Features of Children with Positive Serum Antiendomysium Antibodies and Architecturally Normal Small Intestinal Mucosa , 2005, The American Journal of Gastroenterology.

[37]  G. Corazza,et al.  Coeliac disease , 2005, Journal of Clinical Pathology.

[38]  K. Kaukinen,et al.  Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: A prospective and randomized clinical study , 2005, Scandinavian journal of gastroenterology.

[39]  Govind Bhagat,et al.  Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. , 2004, Immunity.

[40]  Seiamak Bahram,et al.  A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. , 2004, Immunity.

[41]  E. Chang,et al.  Role and regulation of intestinal epithelial heat shock proteins in health and disease. , 2004, Chinese journal of digestive diseases.

[42]  Vahid Asnafi,et al.  Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. , 2003, Gastroenterology.

[43]  V. Raia,et al.  Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease , 2003, The Lancet.

[44]  A. Sette,et al.  Celiac Disease Association with CD8+ T Cell Responses: Identification of a Novel Gliadin-Derived HLA-A2-Restricted Epitope1 , 2003, The Journal of Immunology.

[45]  J. Murray,et al.  HLA-DQ Determines the Response to Exogenous Wheat Proteins: A Model of Gluten Sensitivity in Transgenic Knockout Mice1 , 2002, The Journal of Immunology.

[46]  R. Winchester,et al.  TCR specificity dictates CD94/NKG2A expression by human CTL. , 2002, Immunity.

[47]  Arthur I. Roberts,et al.  Cutting Edge: NKG2D Receptors Induced by IL-15 Costimulate CD28-Negative Effector CTL in the Tissue Microenvironment1 , 2001, The Journal of Immunology.

[48]  R. Jian,et al.  Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease☆☆☆ , 2000, Gastroenterology.

[49]  D. Schuppan,et al.  Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.

[50]  M. Mäki,et al.  Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells. , 1994, Gut.

[51]  M. Mäki,et al.  Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsy findings. , 1993, Scandinavian journal of gastroenterology.

[52]  A. Ferguson,et al.  Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential. , 1993, Gut.

[53]  J. Madara,et al.  Structural abnormalities of jejunal epithelial cell membranes in celiac sprue. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[54]  D. Armstrong,et al.  Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity. , 2011, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.